Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference

Rhea-AI Summary

Neumora Therapeutics (Nasdaq: NMRA), a clinical-stage biopharmaceutical company focused on novel mechanisms for prevalent, underserved diseases, will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2026 at 1:35 p.m. ET.

A live webcast and 30-day replay will be accessible via the events and presentations section of the company’s website.

Argus May 13 session

-6.32% close to close Open Argus

Details

News Market Reaction – NMRA

On May 13, the first trading day after this news, NMRA closed 6.32% below the previous close.

Data tracked by StockTitan Argus for the May 13 session.

Market Context

On May 13, the first trading day after this news, the stock closed 6.3% below the previous close. A ...

Analysis

On May 13, the first trading day after this news, the stock closed 6.3% below the previous close. A negative reaction despite neutral conference news fits a backdrop where prior fundamental updates sometimes led to sharp downside, even when cash runway and pipeline progress were reiterated. The RBC conference appearance adds visibility but no new financial or clinical data, so any outsized decline could have reflected profit-taking near recent highs or lingering concerns from past earnings reactions. Historical volatility around results and material filings suggests that sentiment shifts have played a meaningful role in prior drawdowns.

Key Figures

Conference date: May 19, 2026 Presentation time: 1:35 p.m. ET Webcast archive period: 30 days

Conference date

May 19, 2026

RBC Capital Markets Global Healthcare Conference fireside chat

Presentation time

1:35 p.m. ET

Scheduled time for RBC conference fireside chat

Webcast archive period

30 days

Replay of the RBC fireside chat available on company website

Historical Context

5 past events · Latest: May 07

5 events

1. May 07

   Q1 2026 earnings

   24h Move

   -16.7%

   Q1 2026 results and business update with cash runway into Q3 2027.

2. Apr 06

   Conference participation

   24h Move

   +6.0%

   Announcement of Needham virtual healthcare conference fireside chat webcast.

3. Mar 30

   FY 2025 earnings

   24h Move

   -17.2%

   Q4 and full-year 2025 results with Phase 3 and pipeline milestones outlined.

4. Mar 16

   Earnings date notice

   24h Move

   +1.0%

   Scheduling notice for Q4 and FY 2025 results call and webcast details.

5. Feb 04

   Conference participation

   24h Move

   -1.0%

   Participation in Guggenheim biotech summit with webcast and replay access.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WATERTOWN, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases, today announced that the Company will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2026 at 1:35 p.m. ET.

A live webcast of the fireside chat will be available on the events and presentations section of the Company’s website at www.neumoratx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Neumora
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the greatest medical challenges of our generation by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our therapeutic pipeline currently consists of programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases. Neumora’s mission is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients.

Neumora Contact:
Helen Rubinstein
617-402-5700
Helen.Rubinstein@neumoratx.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Neumora Therapeutics (NMRA) present at the 2026 RBC Capital Markets Global Healthcare Conference?

Neumora Therapeutics will participate in a fireside chat on Tuesday, May 19, 2026 at 1:35 p.m. ET. According to the company, this session is part of the 2026 RBC Capital Markets Global Healthcare Conference.

How can investors watch Neumora Therapeutics' 2026 RBC conference webcast for NMRA?

Investors can watch the fireside chat via a live webcast on Neumora’s website. According to the company, access is provided in the events and presentations section at www.neumoratx.com.

Will a replay of Neumora Therapeutics (NMRA) 2026 RBC conference presentation be available?

Yes, a replay of the webcast will be available after the event. According to Neumora Therapeutics, the archived replay will remain accessible on its website for up to 30 days.

Where on Neumora Therapeutics' website can I find the NMRA 2026 RBC Healthcare Conference webcast?

The webcast will be hosted in the events and presentations section of Neumora’s website. According to the company, investors should visit www.neumoratx.com to access both the live stream and replay.

What type of event is Neumora Therapeutics (NMRA) holding at the 2026 RBC Healthcare Conference?

Neumora Therapeutics will participate in a fireside chat at the conference. According to the company, this discussion will be webcast live and later archived online for up to 30 days.